|
Delayed
Nasdaq
|
5-day change | 1st Jan Change | ||
| - USD | -.--% |
|
-.--% | - |
| 19/01/21 | Integra LifeSciences Holdings Corporation completed the acquisition of ACell, Inc for approximately $410 million. | CI |
| 22/12/20 | ACell, Inc. Announces CE Mark Approval | CI |
| Manager | Title | Age | Since |
|---|---|---|---|
Matthew R. Kunst
DFI | Director of Finance/CFO | - | 31/12/2019 |
Patty Meehan
ADM | Chief Administrative Officer | - | 31/12/2001 |
Jim Kuras
CTO | Chief Tech/Sci/R&D Officer | - | 31/12/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Kyle C. Kerbawy
CHM | Chairman | 79 | 31/07/2015 |
Sally L. Maher
BRD | Director/Board Member | - | 30/04/2019 |
| Director/Board Member | 71 | 30/06/2019 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 340M | |
| +0.32% | +3.07% | -14.01% | +5.66% | 192B | |
| -0.20% | +5.42% | -2.51% | +8.54% | 116B | |
| -1.32% | -4.62% | +6.52% | +65.45% | 59.95B | |
| -0.09% | +3.49% | +37.84% | +64.46% | 54.64B | |
| -0.88% | +2.77% | -7.14% | -35.54% | 50B | |
| +0.75% | +10.19% | +14.41% | -18.09% | 34.26B | |
| +0.23% | +3.10% | - | - | 31.15B | |
| -1.74% | -0.70% | +40.59% | -12.31% | 24.79B | |
| +1.43% | +12.01% | -3.33% | +25.23% | 24.07B | |
| Average | -0.15% | +3.32% | +9.05% | +12.92% | 58.73B | |
| Weighted average by Cap. | -0.11% | +3.16% | +0.97% | +13.37% |
| 2018 | 2019 | |
|---|---|---|
| Net sales | 89.22M 77.34M 72.5M 66.1M 124M 8.52B 126M 854M 333M 4.26B 335M 328M 14.22B | 101M 87.37M 81.9M 74.68M 141M 9.62B 143M 964M 376M 4.82B 378M 370M 16.06B |
| Net income | -3.13M -2.71M -2.54M -2.32M -4.37M -299M -4.44M -29.96M -11.7M -150M -11.76M -11.5M -499M | 1.45M 1.26M 1.18M 1.07M 2.02M 138M 2.05M 13.86M 5.41M 69.21M 5.44M 5.32M 231M |
| Net Debt | - | - |
Employees
-
- Stock Market
- Stocks
- ACLL Stock
Select your edition
All financial news and data tailored to specific country editions
